Top compounds associated with response to MTHFSD


Feature Type Standardized
Nominal ANOVA
mRNA Mdivi-1 CTRPv2 pan-cancer AAC -0.062 0.09
mRNA HG-5-113-01 GDSC1000 pan-cancer AAC -0.079 0.09
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.05 0.09
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.09
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.056 0.1
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC -0.062 0.1
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.061 0.1
mRNA etoposide CTRPv2 pan-cancer AAC -0.05 0.1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.1
mRNA Methotrexate FIMM pan-cancer AAC 0.22 0.1
Download CSV